Skip to main content
SpringerLink
Log in

Anti-egfr-car-transduced-t-cells/nivolumab

Various toxicities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Feng K-C, et al. Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma. Journal of Hematology and Oncology 10: 1-11, No. 1, 5 Jan 2017. Available from: URL: http://doi.org/10.1186/s13045-016-0378-7 - China

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anti-egfr-car-transduced-t-cells/nivolumab. Reactions Weekly 1640, 36 (2017). https://doi.org/10.1007/s40278-017-26589-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-26589-6

Search

Navigation